Antimicrobial and lipopolysaccharide-binding activities of C-terminal domain of human CAP18 peptides to genus Leptospira

Journal of Applied Research

Volumn 4, Issue 1, 2004, Pages 180-185

  Isogai, Emiko ^a   Hirata, Michihisa ^b   Isogai, Hiroshi ^c   Matsuo, Kouki ^d   Watarai, Satoshi ^e   Miura, Hiroko ^f   Oguma, Keiji ^g  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b Research Division of Innate Immunity   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^e Osaka Furitu University   (Japan)

^f KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^g OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Antimicrobial effect; CAP18; Leptospira; LPS

Indexed keywords

AMINO ACID; ANTIMICROBIAL PEPTIDE CAP18; BACTERIUM LIPOPOLYSACCHARIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENTEROBACTER; LEPTOSPIRA; LEPTOSPIRA BIFLEXA; LEPTOSPIRA INTERROGANS; LEUKOCYTE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN;

EID: 6444234288     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Faine S, Adler B, Bolin C, Perolat P. Leptospira and leptospirosis. 2nd ed. Melbourne, Australia: Medisci Press; 1999.
2. Isogai E, Kitagawa H, Isogai H, Kurebayashi Y, Ito N. Phagocytosis as a defense mechanism against infection with leptospiras. Zentralbl Backteriol Hyg. 1986;A261:65-74.
3. Isogai E, Isogai H, Wakizaka H, Miura H, Kurebayashi Y. Chemiluminescence and phagocytic responses of rat polymorphonuclear neutrophils to leptospires. Zentralbl Bakteriol Hyg. 1989;A272:36-46.
4. McGraph H, Adler B, Vinh T, Faine S. Phagocytosis of virulent and avirulent leptospires by guinea-pig and human polymorphonuclear leukocytes in vitro. Pathology. 1984;16:243-249.
5. Wang B, Sullivan J, Sullivan GW, Mandell GL. Interaction of leptospires with human polymorphonuclear neutrophils. Infect Immun. 1984;44:459-464.
6. Vinh T, Adler B, Faine S. The role of macrophages in the protection of mice against leptospirosis: In vitro and in vivo studies. Pathology. 1982;14:463-468.
7. Faine S, Shahar A, Aronson M. Phagocytosis and its significance in leptospiral infection. Aust J Exp Biol Med Sci. 1964;42:579-588.
8. Larrick JW, Hirata M, Zheng H, et al. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol. 1994;152:231-240.
9. Zasloff M. Antimicrobial peptides in health and disease. N Engl J Med. 2002;347:1199-1200.
10. Hirata M, Shimomura Y, Yosida M, et al. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect Immun. 1994;62:1421-1426.
11. Larrick JW, Hirata M, Balint RF, Lee J, Zhong Z, Wright SC. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun. 1995;63:1291-1297.
12. Hirata M, Wright SC, Larrick JW. Endotoxin-neutralizing proteins for sepsis and endotoxin shock. In: Okada K, Ogata H, eds. Shock. Amsterdam, Holland: Elsevier Science; 1996:109-115.
13. Hirata M, Zhong J, Wright SC, Larrick JW. Structure and functions of endotoxin-binding peptides derived from CAP18. In: Levin J, Alving CR, Munford RS, Redl H, eds. Bacterial endotoxins: lipopolysaccharides from genes to therapy. New York, NY: Wiley-Liss, Inc; 1995:317-326.
14. Nagaoka I, Hirota S, Niyonsaba F, et al. Cathelicidin family of antimicrobial peptides CAP18 and CAP11 inhibit the expression of TNF-α by blocking the binding of LPS to CD14+ cells. J Immunol. 2001;167:3329-3338.
15. Kirikae T, Hirata M, Yamasu H, et al. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun. 1998;66:1861-1868.
16. Isogai E, Isogai H, Kurebayashi Y, Ito N. Biological activities of leptospiral lipopolysaccharide. Zentralbl Bakteriol Hyg A. 1986;261:53-64.
17. Isogai E, Isogai H, Kubota T, et al. Apoptosis of lymphocytes in mice administered lipopolysaccharide from Leptospira interrogans. J Vet Med. 1998;B45:529-537.
18. Scocchi M, Romeo D, Cinco M. Antimicrobial activity of two bactenecins against spirochetes. Infect Immun. 1993;61:3081-3083.
19. n units in the antigenic polysaccharides from Leptospira biflexa serovar patoc strain Patoc I. Carbohydrate Res. 2000;328:517-524.
20. Lusitani D, Malawista SE, Montgomery RR. Borrelia burgdorferi are susceptible to killing by a variety of human polymorphonuclear leukocyte components. J Inf Dis. 2002;185:797-804.
21. Vaara M. Agents that increase the permeability of the outer membrane. Micorbiol Rev. 1992;56:395-411.
22. Swierzko AST, Kirikae T, Kirikae F, et al. Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide. J Med Microbiol. 2000;49:127-138.